Kai Yu

Kai Yu

Auto-generated profile, based on publicly available information

Kai Yu

Centre for Blood Research and Life Sciences Institute University of British Columbia 2350 Health Sciences Mall Vancouver BC V6T 1Z3 Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in ACS Nano
Verified
Journal Article
Closed access
XZXiaoxiao Zhao
Xiaoxiao Zhao
BKBehrooz Khatir
Behrooz Khatir
KMKiana Mirshahidi
Kiana Mirshahidi
KYKai Yu
Kai Yu
JKJayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu
KGKevin Golovin
Kevin Golovin

12 November 2024 in Nature Materials
Verified
Journal Article
Open access
PDF file
HJHaifeng Ji
Haifeng Ji
KYKai Yu
Kai Yu
SASrinivas Abbina
Srinivas Abbina
LXLin Xu
Lin Xu
TXTao Xu
Tao Xu
JKJayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu
Antithrombotic surfaces that prevent coagulation activation without interfering with haemostasis are required for blood-contacting devices. Such materials would restrain device-induced thrombogenesis and decrease the need for anticoagulant use, thereby reducing unwanted bleeding. Here, by optimizing the interactions with coagulation factor XII rather than preventing its surface adsorption, we develop a substrate-independent antithrombotic polymeric coating with sheltered positive charges. The antithrombic properties of the coating were demonstrated in vitro with human blood and in vivo using a carotid artery–jugular vein shunt model in rabbits. The coating exhibits a strong interaction with factor XII, but results in a low reciprocal activation of the contact pathway that triggers clot formation. These findings contradict the prevailing strategy of designing antithrombotic materials through protein-repelling surfaces. Overall, the polymeric coating we describe can benefit most blood-contacting devices and is a useful engineering guideline for designing surfaces with improved antithrombotic properties.

20 January 2021 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
KYKai Yu
Kai Yu
AAAmal Alzahrani
Amal Alzahrani
SKSara Khoddami
Sara Khoddami
DFDemian Ferreira
Demian Ferreira
KSKymora B. Scotland
Kymora B. Scotland
JKJayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu

30 July 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
KYKai Yu
Kai Yu
AAAmal Alzahrani
Amal Alzahrani
SKSara Khoddami
Sara Khoddami
JCJohn T. J. Cheng
John T. J. Cheng
YMYan Mei
Yan Mei
JKJayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu

14 December 2022 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
KYKai Yu
Kai Yu
RWReid Warsaba
Reid Warsaba
HYHossein Yazdani-Ahmadabadi
Hossein Yazdani-Ahmadabadi
DLDirk Lange
Dirk Lange
EJEric Jan
Eric Jan
JKJayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu

7 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Tiev MillerTiev Miller
Tiev Miller
Dirk LangeDirk Lange
Dirk Lange
JKJayachandran N. Kizhakkedathu
Jayachandran N. Kizhakkedathu
KYKai Yu
Kai Yu
DFDemian Felix
Demian Felix
AKAndrei Krassioukov
Andrei Krassioukov
Despite the risk of developing catheter-associated urinary tract infections (CAUTI), catheter reuse is common among people with spinal cord injury (SCI). This study examined the microbiological burden and catheter surface changes associated with short-term reuse. Ten individuals with chronic SCI reused their catheters over 3 days. Urine and catheter swab cultures were collected daily for analysis. Scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS) analyses were used to assess catheter surface changes. Catheter swab cultures showed no growth after 48 h (47.8%), skin flora (28.9%), mixed flora (17.8%), or bacterial growth (5.5%). Asymptomatic bacteriuria was found for most participants at baseline (n = 9) and all at follow-up (n = 10). Urine samples contained Escherichia coli (58%), Klebsiella pneumoniae (30%), Enterococcus faecalis (26%), Acinetobacter calcoaceticus–baumannii (10%), Pseudomonas aeruginosa (6%) or Proteus vulgaris (2%). Most urine cultures showed resistance to one or more antibiotics (62%). SEM images demonstrated structural damage, biofilm and/or bacteria on all reused catheter surfaces. XPS analyses also confirmed the deposition of bacterial biofilm on reused catheters. Catheter surface changes and the presence of antibiotic-resistant bacteria were evident following short-term reuse, which may increase susceptibility to CAUTI in individuals with SCI despite asymptomatic bacteriuria.